More on albumin
- 1 May 1999
- Vol. 318 (7192) , 1214
- https://doi.org/10.1136/bmj.318.7192.1214b
Abstract
# Use of human albumin in UK fell substantially when systematic review was published {#article-title-2} EDITOR—After publication of the Cochrane Injuries Group Albumin Reviewers' systematic review of albumin administration in critically ill patients1 the Committee on Safety of Medicines convened an expert working party to consider the implications for the use of albumin in the United Kingdom. To date the committee has not made any announcement. The results of the review were widely reported in the medical and lay press,2 and this may have influenced the use of albumin. We requested data on the monthly issues of albumin solutions to regional blood centres and hospitals between 1993 and 1999 from the Bio Products Laboratory (which serves England and Wales) and the Protein Fractionation Centre of the Scottish National Blood Transfusion Service (which serves Scotland and Northern Ireland). Issues were expressed in kg of albumin, reflecting the total albumin content of the various dose units. A …Keywords
This publication has 6 references indexed in Scilit:
- Human albumin administration in critically ill patients. Evidence needs to be shown in paediatrics.1998
- Human albumin administration in critically ill patients. Review did not provide recommendations for alternative treatment.1998
- Human albumin administration in critically ill patientsBMJ, 1998
- Albumin: don't confuse us with the factsBMJ, 1998
- Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not workBMJ, 1998
- Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trialsBMJ, 1998